ARCHIVES

Drug Development: FDA Grants Breakthrough Therapy Designation To CTL019 in ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 24 | June 11, 2014

Download PDF Visit The Full Archive

Related Articles

Medicare to cut payments for cancer drugs by 2-8%. ASCO estimates total cut in reimbursement at $500 million.

July 30, 2004

Letter Protests Closed Meeting; NIH Calls Action Appropriate

August 12, 1994

October issue of Business & Regulatory Report (8-page issue).

November 2, 2002

Indoor Tanning Industry Funded Author Of NEJM Review On Vitamin D Deficiency.

April 18, 2008

Peer Review Study Team Plans Hearing

December 12, 1975

New GAO Report Critical Of federal Effort Against Environmental Carcinogenesis

June 25, 1976